Citation Impact
Citing Papers
Inhibitory effect of progesterone and 20α-hydroxypregn-4-en-3-one on the phytohemagglutinin-induced transformation of human lymphocytes
1977 StandoutNobel
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
2008
Management of Acne
2003
Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day)
2000
In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp.
2004 Standout
Endometriosis
2009 Standout
Psychogenic Infertility—Myths and Facts
2003 Standout
17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium.
1994
Comparison of flutamide and spironolactone in the treatment of hirsutism: a randomized controlled trial
1994
Alopecia areata update
2010 Standout
Results of an Open One‐Year Study with Diane‐35 in Women with Polycystic Ovarian Syndrome
1993
Polycystic Ovary Syndrome
1995 Standout
Acne vulgaris
2011 Standout
HAIR REGROWTH
1998
Polycystic Ovary Syndrome
2005 Standout
A Risk-Benefit Assessment of Pharmacological Therapies for Hirsutism
2001
POLYCYSTIC OVARIES—A COMMON FINDING IN NORMAL WOMEN
1988 Standout
Treatment of hirsutism with the pure antiandrogen flutamide
1990
Oxidative Stress, Antioxidants, and Animal Function
1993 Standout
17α-Hydroxylase/17,20-Lyase Deficiency: From Clinical Investigation to Molecular Definition*
1991
Liposomal drug delivery systems: From concept to clinical applications
2012 Standout
Polycystic ovary syndrome
2016 Standout
Liposomes in cosmeceutics
2012
Cyproterone acetate for severe hirsutism:results of a double‐blind dose‐ranging study*
1991
Spironolactone as a single agent for long‐term therapy of hirsute patients
2000
Antiandrogens in the treatment of acne and hirsutism
1983
Coping mechanisms in infertile women with luteal phase insufficiency
1989
A Prospective Randomized Trial Comparing Low Dose Flutamide, Finasteride, Ketoconazole, and Cyproterone Acetate-Estrogen Regimens in the Treatment of Hirsutism
1999
Suppression of mixed lymphocyte reaction by progesterone and estradiol-17β
1979 StandoutNobel
Comparative Effects of Cyproterone Acetate or a Long-Acting Gonadotropin-Releasing Hormone Agonist in Polycystic Ovarian Disease
1986
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
2011 Standout
Ovulatory Disorders in Women with Polycystic Ovary Syndrome
1985
The polycystic ovary syndrome presenting as resistant acne successfully treated with cyproterone acetate
1991
Alopecia areata update
2000 Standout
Essential fatty acids and acne
1986
4 Anti-androgens in gynaecological practice
1988
11 Treatment of hirsutism and acne with cyproterone acetate
1986
Works of F. Zielske being referenced
Antiandrogene
1973
TREATMENT OF HIRSUTISM AND OTHER SIGNS OF VIRILISM WITH A REVERSED SEQUENTIAL ADMINISTRATION OF CYPROTERONE ACETATE AND ETHINYL OESTRADIOL CLINICAL AND ENDOCRINOLOGICAL ASPECTS
1971
17α-HYDROXYLASE DEFICIENCY OF THE GONADS AND ADRENALS IN A MALE PSEUDOHERMAPHRODITE
1973
STUDIES ON THE METABOLISM OF C-19 STEROIDS IN THE HUMAN FOETO-PLACENTAL UNIT
1967
NORMAL AND DISTURBED FUNCTION OF THE HUMAN CORPUS LUTEUM AS REFLECTED BY HORMONAL ANALYSES IN BLOOD
1970
USE OF CYPROTERONE ACETATE (CPA) IN THE TREATMENT OF ACNE, HIRSUTISM AND VIRILISM
1976
Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism
1975